High Tower Advisors, LLC Eli Lilly & CO Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, High Tower Advisors, LLC holds 411,198 shares of LLY stock, worth $329 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

411,198

Previous 456,196 9.86%

Holding current value

$329 Million

Previous $413 Million 11.8%

% of portfolio

0.53%

Previous 0.64%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $34.7 Million - $43.2 Million	-44,998 Reduced 9.86%	411,198 $364 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $13.6 Million - $17 Million	18,707 Added 4.28%	456,196 $413 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $59.6 Million - $79.7 Million	-100,657 Reduced 18.7%	437,489 $340 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $15.9 Million - $18.7 Million	-30,234 Reduced 5.32%	538,146 $314 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $6.07 Million - $8.37 Million	13,962 Added 2.52%	568,380 $305 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $208,690 - $279,043	595 Added 0.11%	554,418 $260 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $2.51 Million - $2.95 Million	-8,078 Reduced 1.44%	553,823 $190 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $8.43 Million - $9.82 Million	26,209 Added 4.89%	561,901 $206 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $2.54 Million - $2.89 Million	8,554 Added 1.62%	535,692 $173 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $6.99 Million - $8.2 Million	25,071 Added 4.99%	527,138 $171 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $2.79 Million - $3.47 Million	11,881 Added 2.42%	502,067 $144 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $15.1 Million - $18.8 Million	67,316 Added 15.92%	490,186 $136 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $610,508 - $751,316	-2,755 Reduced 0.65%	422,870 $97.7 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $7.11 Million - $9.2 Million	39,402 Added 10.2%	425,625 $97.7 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $6.58 Million - $8.52 Million	40,054 Added 11.57%	386,223 $72.1 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $1.16 Million - $1.53 Million	8,872 Added 2.63%	346,169 $58.5 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $110,103 - $127,354	-753 Reduced 0.22%	337,297 $49.9 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $687,966 - $827,959	5,043 Added 1.51%	338,050 $55.5 Million
Q1 2020 May 21, 2020	SELL	$119.05 - $147.35 $1.43 Million - $1.76 Million	-11,977 Reduced 3.47%	333,007 $46.2 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $2.11 Million - $2.62 Million	19,752 Added 6.07%	344,984 $45.4 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $396,618 - $431,418	3,714 Added 1.16%	325,232 $36.3 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $9.81 Million - $11.4 Million	-88,510 Reduced 21.59%	321,518 $35.6 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $340,163 - $400,397	3,056 Added 0.75%	410,028 $53.2 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $8.31 Million - $9.31 Million	78,454 Added 23.88%	406,972 $47.1 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $1.33 Million - $1.66 Million	15,469 Added 4.94%	328,518 $35.2 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $2.12 Million - $2.43 Million	-27,959 Reduced 8.2%	313,049 $26.7 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.04 Million - $2.41 Million	-27,480 Reduced 7.46%	341,008 $26.4 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $6.3 Million - $6.75 Million	76,848 Added 26.35%	368,488 $31.1 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $198,146 - $219,923	2,571 Added 0.89%	291,640 $25 Million
Q2 2017 Aug 14, 2017	BUY	N/A	289,069	289,069 $23.8 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Eli Lilly & CO Transaction History